The effect of cyclical hormonal changes on erythrocyte electrolyte transport mechanisms

1986 ◽  
Vol 70 (3) ◽  
pp. 263-269 ◽  
Author(s):  
Eileen D. M. Gallery ◽  
Catherine Bean ◽  
Roslyn Grigg ◽  
Douglas M. Saunders
Keyword(s):  
Oral Contraceptive ◽  
Electrolyte Transport ◽  
Hormonal Changes ◽  
Transport Mechanisms ◽  
Time Intervals ◽  
Combined Oral Contraceptive ◽  
Normal Men ◽  
Androgenic Effect ◽  
86Rb Influx

1. Electrolyte transport characteristics were examined in erythrocytes from 13 normal men and from two groups of women: (i) taking combined oral contraceptive preparations (O/C, n = 10), and (ii) ovulatory women (non-O/C, n = 10) pre- and post-ovulation, at the same time intervals (days 7–10 and days 15–18) during a menstrual cycle. 2. With rubidium (86Rb+) used as a potassium analogue, co-transport (ouabain-resistant, fruse-mide-sensitive 86Rb+ influx) values were found to be lowest in non-O/C women (28 ± se 2.5 nmol h−1 10−9 cells) and highest in men (56 ± 5.7, P < 0.001), with results between the two in women taking O/C (42 ± 4.2, P < 0.05 vs men, P < 0.01 vs non-O/C). Passive 86Rb leak (frusemideand ouabain-resistant) was significantly lower in men (13 ± 1.6 nmol h−1 10−9 cells) than in both groups of women (non-O/C 29 ± 1.8, P < 0.001; O/C 25 ± 1.2, P < 0.001). There was no cyclical variation within either group of women. 3. Maximum ouabain binding (number of Na+,K+-ATPase units) was the same in all groups. Na+,K+-ATPase activity, as determined by ouabain-sensitive 86Rb influx, was the same in men and non-O/C groups, but was significantly suppressed in O/C compared with both men (P < 0.01) and non-O/C women (P < 0.05). 4. The differences found were not due to alterations in either progesterone or aldosterone, but could represent an androgenic effect in vivo of the 19-nortestosterone derivatives in combined oral contraceptive preparations.

Serum copper in rural women taking combined oral contraceptive

2007 ◽  
Vol 15 (1) ◽  
Author(s):  
S Akhter ◽  
AK Shamsuzzaman ◽  
M Banarjee ◽  
SA Seema ◽  
K Deb
Keyword(s):  
Oral Contraceptive ◽  
Rural Women ◽  
Serum Copper ◽  
Combined Oral Contraceptive

ÉTUDES IN VIVO SUR LE MÉTABOLISME DES ANDROGÉNES APRES ADMINISTRATION DE STÉROÏDES INHIBITEURS DE L'OVULATION

1965 ◽  
Vol 50 (1) ◽  
pp. 131-144 ◽  
Author(s):  
P. Mauvais-Jarvis ◽  
M. F. Jayle ◽  
J. Decourt ◽  
J. Louchart ◽  
J. Truffert
Keyword(s):  
Luteinizing Hormone ◽  
Urinary Excretion ◽  
Normal Subjects ◽  
Hormone Activity ◽  
Testosterone Production ◽  
Normal Men ◽  
Ethinyl Oestradiol

ABSTRACT Normal subjects and hirsute women with micropolycystic ovaries were treated with ethinyl-oestrenol + 3-methoxy-ethinyl-oestradiol (Lyndiol®), in view of studying the action of this compound on the production of androgens and on the urinary excretion of their metabolites. In normal men, the production of testosterone and the excretion of androsterone and aetiocholanolone are suppressed, whereas the excretion of other 17-ketosteroids and the production of dehydroepiandrosterone sulphate are unchanged. Moreover, the luteinizing hormone activity (LH) in plasma is depressed. It seems that the preparation inhibits specifically the testicular androgen production, by suppressing the hypothalamo-hypophyseal control of LH. Testosterone production and urinary 17-ketosteroid excretion are modified in the same way in women with Stein-Leventhal's syndrome. Physiopathological and therapeutical implications which come from these results are discussed.

Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception

GYNECOLOGY ◽  
2018 ◽  
Vol 20 (2) ◽  
pp. 9-13
Author(s):  
A R Khachaturian ◽  
E V Misharina ◽  
M I Yarmolinskaya
Keyword(s):  
Blood Pressure ◽  
Body Weight ◽  
Oral Contraceptive ◽  
Waist Circumference ◽  
Young Women ◽  
Iron Metabolism ◽  
Serum Iron ◽  
The Body ◽  
Menstrual Bleeding ◽  
Combined Oral Contraceptive

Androgen-dependent dermopathy, as well as premenstrual syndrome of varying severity in young women, can cause emotional depression, difficulties in social adaptation and even depressive disorders. The aim of the study was to study the safety and efficacy of using a combined oral contraceptive (COC) Dimia® containing 20 μg ethinyl estradiol and 3 mg drospirenone in young women, as well as its therapeutic effects in androgen-dependent dermopathy. Materials and methods. The study included 57 young women aged 23.1±2.2 years with signs of androgen-dependent dermopathy. The evaluation of the change in the character of menstrual bleeding, the anthropometric parameters (body weight, waist circumference and hips), the therapeutic effect of the drug on the symptoms of androgen-dependent dermopathy, as well as the dynamics of arterial pressure, hemoglobin level, serum iron have been studied. The psycho-emotional state was assessed using the SAN questionnaire (well-being-activity-mood). Results. During 6 months of observation, there was no significant change in the body mass index, waist circumference, and hips, and the drug did not affect the blood pressure numbers. Against the background of taking the drug, there was an increase in the parameters of iron metabolism (hemoglobin content, serum iron). After 3 months of taking the contraceptive with drospirenone, the number of patients with a complaint about the abundance of menstruation decreased more than twofold (from 22.8 to 10.5%), and after 6 months of taking the drug no patient noted the profuse nature of menstruation. Before the start of taking COC with drospirenone, 57.9% of women reported painful menstrual bleeding. Against the background of taking the contraceptive within 3 months, this complaint was stopped in all patients. Sufficient efficacy of treatment of androgen dependent dermopathy in young women with the help of a microdosed drospirenone-containing combined oral contraceptive is estimated from the dermatological acne index. The analysis of the SAN questionnaire made it possible to reveal the improvement in the psychoemotional state of patients on the background of taking the drug. The conclusion. The results obtained proved the effectiveness and safety of the microclinized COC Dimia®. The drug has no significant effect on body weight, blood pressure, provides reliable control of the cycle and a decrease in menstrual bleeding, which results in stabilization of iron metabolism in the body. Dimia® is effective in the treatment of androgen-dependent dermopathy and can be recommended to young women for starting contraception.

Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/Drospirenone (Yasmin®) in Healthy Chinese Women

2010 ◽  
pp. 1
Author(s):  
Fan Guang-Sheng ◽  
Bian Mei-Lu ◽  
Cheng Li-Nan ◽  
Cao Xiao-Ming ◽  
Huang Zi-Rong ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Chinese Women ◽  
Efficacy And Safety ◽  
Combined Oral Contraceptive ◽  
Healthy Chinese

Effect of Combined Oral Contraceptive Use on Bone Mineral Density in Adolescent Females

2012 ◽  
Vol 23 (3) ◽  
pp. 179-185
Author(s):  
Ling GAI ◽  
Xia LIU ◽  
Ping GAI ◽  
Ai-dong ZHANG ◽  
Ping JIANG ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Oral Contraceptive ◽  
Bone Mineral ◽  
Contraceptive Use ◽  
Adolescent Females ◽  
Mineral Density ◽  
Combined Oral Contraceptive ◽  
Oral Contraceptive Use

scholarly journals Prolactin and Male Fertility: The Long and Short Feedback Regulation

2009 ◽  
Vol 2009 ◽  
pp. 1-13 ◽  
Author(s):  
M. K. Gill-Sharma
Keyword(s):  
Chromatin Condensation ◽  
Feedback Regulation ◽  
Pituitary Hormones ◽  
Feedback Mechanism ◽  
Reproductive Hormones ◽  
Male Rats ◽  
Normal Men

In the last 20 years, a pituitary-hypothalamus tissue culture system with intact neural and portal connections has been developed in our lab and used to understand the feedback mechanisms that regulate the secretions of adenohypophyseal hormones and fertility of male rats. In the last decade, several in vivo rat models have also been developed in our lab with a view to substantiate the in vitro findings, in order to delineate the role of pituitary hormones in the regulation of fertility of male rats. These studies have relied on both surgical and pharmacological interventions to modulate the secretions of gonadotropins and testosterone. The interrelationship between the circadian release of reproductive hormones has also been ascertained in normal men. Our studies suggest that testosterone regulates the secretion of prolactin through a long feedback mechanism, which appears to have been conserved from rats to humans. These studies have filled in a major lacuna pertaining to the role of prolactin in male reproductive physiology by demonstrating the interdependence between testosterone and prolactin. Systemic levels of prolactin play a deterministic role in the mechanism of chromatin condensation during spermiogenesis.

Sign in / Sign up

Export Citation Format

Share Document